a Study of SHR1210 in Combination With Paclitaxel-albumin and Carboplatin in Extensive Stage Small Cell Lung Cancer
Condition(s):Extensive Stage Small Cell Lung CancerLast Updated:March 10, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Extensive Stage Small Cell Lung CancerLast Updated:March 10, 2021Unknown status
Condition(s):Carcinoma, Small Cell; Small Cell Lung CancerLast Updated:July 26, 2018Completed
Condition(s):Small Cell Lung CancerLast Updated:September 15, 2023Suspended
Condition(s):Small-cell Lung CancerLast Updated:May 3, 2023Recruiting
Condition(s):Small Cell Lung CancerLast Updated:November 20, 2009Terminated
Condition(s):Small-cell Lung CancerLast Updated:September 2, 2020Unknown status
Condition(s):Small Cell Lung CancerLast Updated:March 4, 2021Not yet recruiting
Condition(s):Limited Stage Small Cell Lung CancerLast Updated:May 17, 2023Not yet recruiting
Condition(s):Extensive-stage Small Cell Lung CancerLast Updated:March 22, 2024Recruiting
Condition(s):Small-cell Lung CancerLast Updated:January 5, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.